Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.

McDougle, C J; Goodman, W K; Price, L H; Delgado, P L; Krystal, J H; Charney, D S; Heninger, G R

McDougle, C J; Goodman, W K; Price, L H; Delgado, P L; Krystal, J H; Charney, D S; Heninger, G R.

Affiliation

McDougle CJ; Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519.

Am J Psychiatry ; 147(5): 652-4, 1990 May.

Article in En | MEDLINE | ID: mdl-1970224

Subject(s)

Antipsychotic Agents/therapeutic use; Obsessive-Compulsive Disorder/drug therapy; Oximes/therapeutic use; Serotonin Antagonists/therapeutic use; Adult; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Lithium/therapeutic use; Male; Obsessive-Compulsive Disorder/complications; Obsessive-Compulsive Disorder/psychology; Schizotypal Personality Disorder/complications; Schizotypal Personality Disorder/drug therapy; Tic Disorders/complications; Tic Disorders/drug therapy

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Oximes / Serotonin Antagonists / Antipsychotic Agents / Obsessive-Compulsive Disorder Limits: Adult / Female / Humans / Male Language: En Year: 1990 Type: Article

Search on Google

XML

PubMed Links